The Effects of <i>Berberis vulgaris</i> Fruit Extract on Serum Lipoproteins, apoB, apoA-I, Homocysteine, Glycemic Control and Total Antioxidant Capacity in Type 2 Diabetic Patients
| Author | Farzad Shidfar | en |
| Author | Shima Seyyed Ebrahimi | en |
| Author | Sharieh Hosseini | en |
| Author | Iraj Heydari | en |
| Author | Shahrzad Shidfar | en |
| Author | Giti Hajhassani | en |
| Accessioned Date | 2023-12-27T09:12:25Z | |
| Available Date | 2023-12-27T09:12:25Z | |
| Issued Date | 2012-04-30 | en |
| Abstract | Type 2 diabetes is a well-known endocrine and metabolic disorder which has reached epidemic proportions worldwide and represents a serious public health concern. Hyperglycemia and dyslipidemia are two major abnormalities which are major cardiovascular risk factors. Berberine is a major alkaloid in Berberis vulgaris fruit extract (BVFE) which have important role in regulation of serum glucose and fat metabolism in-vivo and in-vitro but its role in type 2 diabetes have not been extensively examined. | en |
| DOI | https://doi.org/10.22037/ijpr.2012.1155 | en |
| URI | https://repository.brieflands.com/handle/123456789/56511 | |
| Keyword | Berberis vulgaris | en |
| Keyword | Diabetes | en |
| Keyword | ApoB | en |
| Keyword | ApoA-I | en |
| Keyword | Antioxidant | en |
| Keyword | Lipoproteins | en |
| Publisher | Brieflands | en |
| Title | The Effects of <i>Berberis vulgaris</i> Fruit Extract on Serum Lipoproteins, apoB, apoA-I, Homocysteine, Glycemic Control and Total Antioxidant Capacity in Type 2 Diabetic Patients | en |
| Type | Original Article_imported | en |